Potentially new asthma treatment identified
Researchers have been able to uncover a potential new treatment approach for helping patients suffering from asthma by blocking a powerful immune system chemical, which is present in large quantities in patients as per a small study in Thorax.
Severe asthma, which is rare, can be noticed in 1 out of every 10 asthmatics and progressively high doses of steroids are needed to control the disease symptoms.
From Sciencedaily.com:
Seventeen people with severe asthma who still had symptoms, despite being treated with a range of drugs, were also given 25 mg of a drug that blocks TNF alpha production (etanercept) twice weekly, injected below the skin for 12 weeks. Fifteen completed the course.
At the end of the study period, these patients experienced a significant improvement in symptoms and lung function. Two patients were able to discontinue one of their drugs.
The treatment also curbed the inflammatory reaction in the lungs, known as bronchial hyperresponsiveness. And there were few side effects.
The authors caution that further research will be required before this approach can be recommended, but they say that it offers a potentially new avenue of treatment for severe asthma.
Tumor necrosis factor alpha (TNF alpha), which is noticed in many chronic inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and psoriasis, was investigated by the research team.


According to scientists from the
Xamiol gel, available on prescription, has been found to be effective in providing considerable relief to individuals suffering from flaking, itching, and soreness that are caused due to scalp psoriasis. Once-daily treatment with this effective gel is all needed to ensure effective handling of psoriasis.
Psoriasis is an inflammatory response that sets off skin cells to develop quickly leading to raised plaques, which are red in color with silvery scales.
Recent Comments